cryptopleurine has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, LH; Chang, YL; Lai, CY; Lee, KH; Pan, SL; Teng, CM; Yang, PC; Yang, XM | 1 |
| Chao, MW; Cheng, YW; Lai, CY; Lee, KH; Pan, SL; Teng, CM; Wang, LT; Yang, XM | 1 |
2 other study(ies) available for cryptopleurine and Neoplasms
| Article | Year |
|---|---|
Depletion of 4E-BP1 and regulation of autophagy lead to YXM110-induced anticancer effects.
Topics: Adaptor Proteins, Signal Transducing; Alkaloids; Antineoplastic Agents; Apoptosis; Autophagy; Cell Cycle Proteins; Cell Proliferation; Cell Survival; HCT116 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Microtubule-Associated Proteins; Neoplasms; Phenanthrenes; Phosphoproteins; Quinolizidines; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2013 |
eIF4E binding protein 1 expression is associated with clinical survival outcomes in colorectal cancer.
Topics: Adaptor Proteins, Signal Transducing; Alkaloids; Antineoplastic Agents; Caco-2 Cells; Cell Cycle Proteins; Cell Line, Tumor; Colorectal Neoplasms; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Neoplasms; Phenanthrenes; Phosphoproteins; Prognosis; Protein Biosynthesis; Quinolizidines; Treatment Outcome; Vascular Endothelial Growth Factor A | 2015 |